Ngā hua rapu - Pless, Miklos

EGFR IHC score for selection of cetuximab treatment: Ready for clinical practice? mā Früh, Martin, Pless, Miklos

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Acute Fatal Liver Toxicity under Erlotinib mā Schacher-Kaufmann, Sabina, Pless, Miklos

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

PET-Negative Gastrointestinal Stromal Tumors mā Williams, Anja, Gutzeit, Andreas, Germer, Michael, Pless, Miklos

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC mā König, David, Meier, Urs R., Klaeser, Bernd, Savic, Spasenija, Pless, Miklos

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A Rare Differential Diagnosis of an Adrenal Mass: A Case Report mā Seidel, Ann-Katrin, Pless, Miklos, Michel, Christian, Soll, Christopher, Hochuli, Caroline, Gubler, Jacques

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Are Four Simple Questions Able to Predict Weight Loss in Outpatients With Metastatic Cancer? A Prospective Cohort Study Assessing the Simplified Nutritional Appetite Questionnaire mā Helfenstein, Seth F., Uster, Alexandra, Rühlin, Maya, Pless, Miklos, Ballmer, Peter E., Imoberdorf, Reinhard

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Early Treatment Response in Non-Small Cell Lung Cancer Patients Using Diffusion-Weighted Imaging and Functional Diffusion Maps – A Feasibility Study mā Reischauer, Carolin, Froehlich, Johannes Malte, Pless, Miklos, Binkert, Christoph Andreas, Koh, Dow-Mu, Gutzeit, Andreas

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis mā Helfenstein, Seth, Riesterer, Oliver, Meier, Urs R., Papachristofilou, Alexandros, Kasenda, Benjamin, Pless, Miklos, Rothschild, Sacha I.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor mā Häfliger, Simon, Seidel, Ann-Katrin, Schoch, Eric, Reichmann, Jan, Wild, Damian, Steinmann-Schwager, Stephanie, Pless, Miklos

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A clinical trial of group-based body psychotherapy to improve bodily disturbances in post-treatment cancer patients in combination with randomized controlled smartphone-triggered b... mā Grossert, Astrid, Meffert, Cornelia, Hess, Viviane, Rochlitz, Christoph, Pless, Miklos, Hunziker, Sabina, Wössmer, Brigitta, Geuter, Ulfried, Meinlschmidt, Gunther, Schaefert, Rainer

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program mā Balmelli, Catharina, Railic, Nikola, Siano, Marco, Feuerlein, Kristin, Cathomas, Richard, Cristina, Valerie, Güthner, Christiane, Zimmermann, Stefan, Weidner, Sabine, Pless, Miklos, Stenner, Frank, Rothschild, Sacha I.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer mā Baty, Florent, Rothschild, Sacha, Früh, Martin, Betticher, Daniel, Dröge, Cornelia, Cathomas, Richard, Rauch, Daniel, Gautschi, Oliver, Bubendorf, Lukas, Crowe, Susanne, Zappa, Francesco, Pless, Miklos, Brutsche, Martin

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Radiomics Feature Activation Maps as a New Tool for Signature Interpretability mā Vuong, Diem, Tanadini-Lang, Stephanie, Wu, Ze, Marks, Robert, Unkelbach, Jan, Hillinger, Sven, Eboulet, Eric Innocents, Thierstein, Sandra, Peters, Solange, Pless, Miklos, Guckenberger, Matthias, Bogowicz, Marta

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging mā Oliveira, Carol, Amstutz, Florian, Vuong, Diem, Bogowicz, Marta, Hüllner, Martin, Foerster, Robert, Basler, Lucas, Schröder, Christina, Eboulet, Eric I., Pless, Miklos, Thierstein, Sandra, Peters, Solange, Hillinger, Sven, Tanadini-Lang, Stephanie, Guckenberger, Matthias

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08) mā Curioni-Fontecedro, Alessandra, Perentes, Jean Yannis, Gelpke, Hans, Xyrafas, Alexandros, Bouchaab, Hasna, Mach, Nicolas, Matzinger, Oscar, Stojcheva, Nina, Frueh, Martin, Weder, Walter, Cathomas, Richard, Gargiulo, Piera, Bubendorf, Lukas, Pless, Miklos, Betticher, Daniel, Peters, Solange

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types mā Denzler, Sarah, Vuong, Diem, Bogowicz, Marta, Pavic, Matea, Frauenfelder, Thomas, Thierstein, Sandra, Eboulet, Eric Innocents, Maurer, Britta, Schniering, Janine, Gabryś, Hubert Szymon, Schmitt-Opitz, Isabelle, Pless, Miklos, Foerster, Robert, Guckenberger, Matthias, Tanadini-Lang, Stephanie

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study mā Rothschild, Sacha I., Betticher, Daniel, Zenhäusern, Reinhard, Anchisi, Sandro, von Moos, Roger, Pless, Miklos, Moosmann, Peter, Popescu, Razvan A., Calderoni, Antonello, Dressler, Marco, Rauch, Daniel, Pederiva, Stefanie, Woelky, Regina, Papet, Claudia, Bühler, Vera, Borner, Markus

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC mā Vuong, Diem, Bogowicz, Marta, Wee, Leonard, Riesterer, Oliver, Vlaskou Badra, Eugenia, D’Cruz, Louisa Abigail, Balermpas, Panagiotis, van Timmeren, Janita E., Burgermeister, Simon, Dekker, André, De Ruysscher, Dirk, Unkelbach, Jan, Thierstein, Sandra, Eboulet, Eric I., Peters, Solange, Pless, Miklos, Guckenberger, Matthias, Tanadini-Lang, Stephanie

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA) mā Joerger, Markus, Metaxas, Yannis, Zaman, Khalil, Michielin, Olivier, Mach, Nicolas, Bettini, Adrienne, Schmitt, Andreas M., Cantoni, Nathan, Caspar, Clemens B., Stettler, Sonja, Malval, Roma, Pless, Miklos, Britschgi, Christian, Renner, Christoph, Koeberle, Dieter, Schulz, Jessica D., Kopp, Christoph, Hayoz, Stefanie, Stathis, Anastasios, von Moos, Roger

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with s... mā Papachristofilou, Alexandros, Hipp, Madeleine M., Klinkhardt, Ute, Früh, Martin, Sebastian, Martin, Weiss, Christian, Pless, Miklos, Cathomas, Richard, Hilbe, Wolfgang, Pall, Georg, Wehler, Thomas, Alt, Jürgen, Bischoff, Helge, Geißler, Michael, Griesinger, Frank, Kallen, Karl-Josef, Fotin-Mleczek, Mariola, Schröder, Andreas, Scheel, Birgit, Muth, Anke, Seibel, Tobias, Stosnach, Claudia, Doener, Fatma, Hong, Henoch S., Koch, Sven D., Gnad-Vogt, Ulrike, Zippelius, Alfred

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa